Incidence and determinants of venous thromboembolism over 90 days in hospitalized and nonhospitalized patients with COVID-19.
COVID-19
epidemiology
risk factors
venous thromboembolism
Journal
Journal of internal medicine
ISSN: 1365-2796
Titre abrégé: J Intern Med
Pays: England
ID NLM: 8904841
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
medline:
13
11
2023
pubmed:
31
7
2023
entrez:
31
7
2023
Statut:
ppublish
Résumé
COVID-19 is associated with an increased risk of venous thromboembolism (VTE), but there is great variation among reported incidence rates. Most previous studies have focused on hospitalized patients with COVID-19, and only a few reports are from population-based registries. We studied the 90-day incidence of VTE, associated risk factors and all-cause mortality in hospitalized and nonhospitalized patients with COVID-19 in a nationwide cohort. Data on hospitalizations and outpatient visits were extracted from two national registries with mandatory reporting linked by a unique national identification number carried by all Norwegian residents. We performed Cox proportional hazards regression to determine risk factors for VTE after infection with SARS-CoV-2. Our study included 30,495 patients with positive SARS-CoV-2 polymerase chain reaction with a mean (SD) age of 41.9 (17.3) years, and 53% were males. Only 2081 (6.8%) were hospitalized. The 90-day incidence of VTE was 0.3% (95% CI: 0.21-0.33) overall and 2.9% (95% CI: 2.3-3.7) in hospitalized patients. Age (hazard ratio [HR] 1.28 per decade, 95% CI: 1.11-1.48, p < 0.05), history of previous VTE (HR 4.69, 95% CI: 2.34-9.40, p < 0.05), and hospitalization for COVID-19 (HR 23.83, 95% CI: 13.48-42.13, p < 0.05) were associated with risk of VTE. The 90-day incidence of VTE in hospitalized and nonhospitalized patients with COVID-19 was in the lower end compared with previous reports, with considerably higher rates in hospitalized than nonhospitalized patients. Risk factors for VTE were consistent with previously reported studies.
Substances chimiques
Anticoagulants
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
721-729Informations de copyright
© 2023 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine.
Références
Guan WJ, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-20.
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42.
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782-93.
Piazza G, Campia U, Hurwitz S, Snyder JE, Rizzo SM, Pfeferman MB, et al. Registry of arterial and venous thromboembolic complications in patients with COVID-19. J Am Coll Cardiol. 2020;76(18):2060-72.
Gabet A, Grave C, Tuppin P, Olié V, Emmerich J. One year prevalence of venous thromboembolism in hospitalized COVID-19 patients in France: patients' characteristics, time trends, and outcomes. Thromb Haemost. 2022;122(9):1532-41.
Poor HD. Pulmonary thrombosis and thromboembolism in COVID-19. Chest 2021;160(4):1471-80.
Knight R, Walker V, Ip S, Cooper JA, Bolton T, Keene S, et al. Association of COVID-19 with major arterial and venous thrombotic diseases: a population-wide cohort study of 48 million adults in England and Wales. Circulation. 2022;146(12):892-906.
Pasha AK, McBane RD, Chaudhary R, Padrnos LJ, Wysokinska E, Pruthi R, et al. Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19. Thromb Res. 2021;207:150-7.
Ho FK, Man KKC, Toshner M, Church C, Celis-Morales C, Wong ICK, et al. Thromboembolic risk in hospitalized and nonhospitalized COVID-19 patients: a self-controlled case series analysis of a nationwide cohort. Mayo Clin Proc. 2021;96(10):2587-97.
Dalager-Pedersen M, Lund LC, Mariager T, Winther R, Hellfritzsch M, Larsen TB, et al. Venous thromboembolism and major bleeding in patients with coronavirus disease 2019 (COVID-19): a nationwide, population-based cohort study. Clin Infect Dis. 2021;73(12):2283-93.
Boyd S, Martin-Loeches I. The incidence of venous thromboembolism in critically ill patients with COVID-19 compared with critically ill non-COVID patients. Ir J Med Sci. 2021;190(4):1317-20.
Go AS, Reynolds K, Tabada GH, Prasad PA, Sung SH, Garcia E, et al. COVID-19 and risk of VTE in ethnically diverse populations. Chest. 2021;160(4):1459-70.
Løvlie A, Blystad H, Bruun T. MSIS celebrates 40 years. Tidsskr Nor Laegeforen. 2015;135(23-24):2136-8.
Ministry of Health and Care Services. Regulation of Norwegian surveillance system for communicable disease. 2003 [updated 18 February 2022; cited 23 December 2022]. Available from: https://lovdata.no/dokument/SF/forskrift/2003-06-20-740
Bakken IJ, Ariansen AMS, Knudsen GP, Johansen KI, Vollset SE. The Norwegian patient registry and the Norwegian registry for primary health care: research potential of two nationwide health-care registries. Scand J Public Health. 2020;48(1):49-55.
World Health Organization. International statistical classification of diseases and related health problems 10th revision. Geneva: World Health Organization; 2019.
Folkehelseinstituttet. COVID-19 Dagsrapport fredag 15. mai 2020. Oslo: Norwegian Institute of Public Health; 2020 [cited 25 July 2020]. Available from: https://www.fhi.no/sv/smittsomme-sykdommer/corona/dags-og-ukerapporter/dags-og-ukerapporter-om-koronavirus/
Whittaker R, Grøsland M, Buanes EA, Beitland S, Bryhn B, Helgeland J, et al. Hospitalisations for COVID-19 - a comparison of different data sources. Tidsskr Nor Laegeforen. 2020;140(18).
Buanes EA, Kvåle R, Barratt-Due A. Norsk intensiv- og pandemiregister: Årsrapport for 2020 med plan for forbetringstiltak. 2021 [updated 14 June 2021; cited 22 September 2022]. Available from: https://www.kvalitetsregistre.no/sites/default/files/2021-06/NiPar%20Årsrapport%202020.pdf
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83.
D'Hoore W, Bouckaert A, Tilquin C. Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol. 1996;49(12):1429-33.
Chen E. Comorbidity index. 2017 [updates 15 November 2017; cited 27 October 2022]. Available from: https://github.com/chvlyl/Comorbidity_Index
Folkehelseinstituttet. Ukerapport uke 48, onsdag 2. Folkehelseinstituttet; 2020 [cited 25 September 2022]. Available from: https://www.fhi.no/globalassets/dokumenterfiler/bibliotek/alt-du-ma-vite-for-a-registrere-referanser-i-endnote.pdf
Magnusson K, Nygård K, Methi F, Vold L, Telle K. Occupational risk of COVID-19 in the first versus second epidemic wave in Norway, 2020. Eurosurveillance. 2021;26(40):2001875.
Wilson EB. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc. 1927;22(158):209-12.
Samuelsen SO, Kongerud J. Interval censoring in longitudinal data of respiratory symptoms in aluminium potroom workers: a comparison of methods. Stat Med. 1994;13(17):1771-80.
Zhang Z, Reinikainen J, Adeleke KA, Pieterse ME, Groothuis-Oudshoorn CGM. Time-varying covariates and coefficients in Cox regression models. Ann Transl Med. 2018;6(7):121.
Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496-509.
Dean AG, Sullivan KM, Soe MM. OpenEpi: open source epidemiologic statistics for public health. 2013 [cited 31 March 2023]. Available from: http://www.openepi.com
Routledge R. Fisher's exact test. In: Encyclopedia of biostatistics. Hoboken: John Wiley & Sons; 2005.
Porfidia A, Valeriani E, Pola R, Porreca E, Rutjes AWS, Di Nisio M. Venous thromboembolism in patients with COVID-19: systematic review and meta-analysis. Thromb Res. 2020;196:67-74.
Nab L, Groenwold RHH, Klok FA, Bhoelan S, Kruip MJHA, Cannegieter SC. Estimating incidence of venous thromboembolism in COVID-19: methodological considerations. Res Pract Thromb Haemost. 2022;6(6):e12776.
Jiménez D, García-Sanchez A, Rali P, Muriel A, Bikdeli B, Ruiz-Artacho P, et al. Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis. Chest. 2021;159(3):1182-96.
Deitelzweig S, Luo X, Nguyen JL, Malhotra D, Emir B, Russ C, et al. Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID-19 in the United States: a retrospective cohort study. J Thromb Thrombolysis. 2022;53(4):766-76.
Xie J, Prats-Uribe A, Feng Q, Wang Y, Gill D, Paredes R, et al. Clinical and genetic risk factors for acute incident venous thromboembolism in ambulatory patients with COVID-19. JAMA Intern Med. 2022;182(10):1063.
Douillet D, Riou J, Penaloza A, Moumneh T, Soulie C, Savary D, et al. Risk of symptomatic venous thromboembolism in mild and moderate COVID-19: a comparison of two prospective European cohorts. Thromb Res. 2021;208:4-10.
Srivastava R, Parveen R, Mishra P, Saha N, Bajpai R, Agarwal NB. Venous thromboembolism is linked to severity of disease in COVID-19 patients: a systematic literature review and exploratory meta-analysis. Int J Clin Pract. 2021;75(12):e14910.
Tan BK, Mainbourg S, Friggeri A, Bertoletti L, Douplat M, Dargaud Y, et al. Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis. Thorax. 2021;76(10):970-9.
Lee Y, Jehangir Q, Li P, Gudimella D, Mahale P, Lin C-H, et al. Venous thromboembolism in COVID-19 patients and prediction model: a multicenter cohort study. BMC Infect Dis. 2022;22(1):462.
Who.int. Tracking SARS-CoV-2 variants. Geneva: World Health Organisation. 2021 [cited 23 December 2022]. Available from: https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/
Folkehelseinstituttet. Ukerapport uke 53, onsdag 6. Folkehelseinstituttet; 2021 [cited 25 September 2022]. Available from: https://www.fhi.no/contentassets/8a971e7b0a3c4a06bdbf381ab52e6157/vedlegg/andre-halvar-2020/2021.01.06-ukerapport-uke-53-covid-19.pdf
Indseth T, Grøsland M, Arnesen T, Skyrud K, Kløvstad H, Lamprini V, et al. COVID-19 among immigrants in Norway, notified infections, related hospitalizations and associated mortality: a register-based study. Scand J Public Health. 2021;49(1):48-56.
Thygesen LC, Ersbøll AK. When the entire population is the sample: strengths and limitations in register-based epidemiology. Eur J Epidemiol. 2014;29(8):551-8.
Wolff C, Lange H, Feruglio S, Vold L, MacDonald E. Evaluation of the national surveillance of Legionnaires' disease in Norway, 2008-2017. BMC Public Health. 2019;19(1):1624.